The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
220 jobs Number of planned job creations
Announcement Date
21 June 2012
Employment effect (start)
21 June 2012
Foreseen end date
31 December 2012
Description
Biovet AD, a subsidiary of Huvepharma SA announced plans to hire 220 new employees at its new plant in Razgrad, Bulgaria. The new staff will be employed by the end of 2012. The company is looking for highly qualified specialists (biologists, chemists, engineers and others).
Biovet AD is a manufacturer of biotechnological and pharmaceutical products sold in 70 countries. Over 98% of its production is for export. The company currently employs 1,700 highly qualified workers.
The main shareholder of Biovet is the multinational company Huverpharma AD specialized in manufacturing and marketing of active pharmaceutical ingredients, veterinary products and animal feed activities. Manufacturing plants and research centres are based in Europe and the USA.
Eurofound (2012), Biovet AD, Business expansion in Bulgaria, factsheet number 73762, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/73762.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
